World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
82
Citations
27005
World Ranking
1494
National Ranking
752

Medicine

D-Index
82
Citations
27007
World Ranking
16031
National Ranking
8066

Joel D. Meyers publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Joel D. Meyers sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 184 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Joel D. Meyers D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Joel D. Meyers sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 82 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Joel D. Meyers was affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research work focused primarily on medicine, with particular contributions in the subfields of infectious diseases, hepatology, immunology, epidemiology, and oncology.

The scientist's main research topics included:

  • SARS-CoV-2 and COVID-19 Research
  • Hepatitis Viruses Studies and Epidemiology
  • Immunotherapy and Immune Responses
  • Cytomegalovirus and herpesvirus research
  • Viral-associated cancers and disorders
  • Parvovirus B19 Infection Studies

Joel D. Meyers contributed to several research papers, including:

  • B-077 Comparison of SARS-CoV-2 Antibody Profile and Omicron-Specific Neutralizing Activity Before and After mRNA Booster Vaccines: Bivalent vs. Original Formulation (2023) published in Clinical Chemistry
  • B-100 Utilization and Performance of Monospot and Epstein-Barr Virus Antibody Profile Testing for Diagnosis of Infectious Mononucleosis in Adolescents and Adults (2024) published in Clinical Chemistry

The scientist frequently collaborated with other researchers, including:

  • Christine Schmotzer
  • Jaime H. Noguez
  • Anne Windau
  • Xiaoliang Yang
  • R Pontoni

The primary venue for Joel D. Meyers's publications was Clinical Chemistry, where they published at least two papers.

Best Publications

  • Risk Factors for Cytomegalovirus Infection after Human Marrow Transplantation

    Joel D. Meyers;Nancy Flournoy;E. Donnall Thomas

  • Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation—A Prospective, Randomized, Double-Blind Study

    M A Slavin;B Osborne;R Adams;M J Levenstein

  • Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.

    Pierre Reusser;Stanley R. Riddell;Joel D. Meyers;Philip D. Greenberg

  • GANCICLOVIR PROPHYLAXIS TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC MARROW TRANSPLANT

    James M. Goodrich;Raleigh A. Bowden;Lloyd Fisher;Claire Keller

  • Early Treatment with Ganciclovir to Prevent Cytomegalovirus Disease after Allogeneic Bone Marrow Transplantation

    Goodrich Jm;Mori M;Gleaves Ca;Du Mond C

  • Treatment of Cytomegalovirus Pneumonia with Ganciclovir and Intravenous Cytomegalovirus Immunoglobulin in Patients with Bone Marrow Transplants

    Elizabeth C. Reed;Raleigh A. Bowden;Paula S. Dandliker;Kathryn E. Lilleby

  • Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience

    J D Meyers;N Flournoy;E D Thomas

  • Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow Transplantation

    R. A. Bowden;M. Sayers;N. Flournoy;B. Newton

  • Adenovirus Infections in Patients Undergoing Bone-Marrow Transplantation

    Anthony F. Shields;Anthony F. Shields;Anthony F. Shields;Robert C. Hackman;Robert C. Hackman;Robert C. Hackman;Kenneth H. Fife;Lawrence Corey;Lawrence Corey;Lawrence Corey

  • Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow Transplantation

    Joel D. Meyers;Joel D. Meyers;Joel D. Meyers;Elizabeth C. Reed;David H. Shepp;David H. Shepp;David H. Shepp;Mark Thornquist;Mark Thornquist;Mark Thornquist

  • Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients

    Balfour Hh;Bean B;Laskin Ol;Ambinder Rf

  • An Outbreak of Respiratory Syncytial Virus in a Bone Marrow Transplant Center

    Robert D. Harrington;Thomas M. Hooton;Thomas M. Hooton;Robert C. Hackman;Robert C. Hackman;Gregory A. Storch;Gregory A. Storch

  • Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia.

    David H. Shepp;Paula S. Dandliker;Paulo de Miranda;Thimysta C. Burnette

  • Infection with varicella- zoster virus after marrow transplantation

    Richard M. Locksley;Nancy Flournoy;Keith M. Sullivan;Joel D. Meyers

  • Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.

    Keith M. Sullivan;Kenneth J. Kopecky;Jane Jocom;Lyly Fisher

  • Herpes Simplex Virus Pneumonia: Clinical, Virologic, and Pathologic Features in 20 Patients

    Paul G. Ramsey;Kenneth H. Fife;Robert C. Hackman;Joel D. Meyers

  • Human Herpesvirus 6 in Lung Tissue from Patients with Pneumonitis after Bone Marrow Transplantation

    Richard W. Cone;Robert C. Hackman;Meei-Li W. Huang;Raleigh A. Bowden

  • Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine.

    David H. Shepp;Paula S. Dandliker;Joel D. Meyers

  • Intravenous Acyclovir to Treat Mucocutaneous Herpes Simplex Virus Infection After Marrow Transplantation: A Double-Blind Trial

    James C. Wade;Barbara Newton;Colin McLAREN;Nancy Flournoy

  • Cytomegalovirus Excretion as a Predictor of Cytomegalovirus Disease after Marrow Transplantation: Importance of Cytomegalovirus Viremia

    Joel D. Meyers;Per Ljungman;Lloyd D. Fisher

Frequent Co-Authors

Robert C. Hackman
Robert C. Hackman University of Washington School of Medicine
E. Donnall Thomas
E. Donnall Thomas University of Washington
Keith M. Sullivan
Keith M. Sullivan Duke University
Jean E. Sanders
Jean E. Sanders Fred Hutchinson Cancer Research Center
Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
George B. McDonald
George B. McDonald University of Washington
Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
Buckner Cd
Buckner Cd National Cancer Institute
Kristine Doney
Kristine Doney Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, complementary healthcare degrees can open diverse career opportunities. Nursing programs, especially specialized tracks, can be a valuable choice. For example, exploring acnp programs offers a pathway to become an Acute Care Nurse Practitioner, which involves advanced clinical roles often related to immunological care.

Many students begin their nursing careers through accelerated options. The accelerated rn to np programs provide busy professionals a faster route from registered nurse to nurse practitioner, allowing for advanced practice in fields connected to Immunology. Meanwhile, non-nurses considering a shift into healthcare can benefit from online absn programs for non nurses, designed to quickly prepare students for registered nursing roles.

Understanding regional salary differences is crucial for career planning in this field. The dnp salary by state resource helps prospective Doctor of Nursing Practice holders assess earning potential across the USA, which is essential when choosing where to study and work in Immunology-related nursing specialties.

Best Scientists Citing Joel D. Meyers

Recently Published Articles